Constructive Bio
Pioneering synthetic biology company building entirely synthetic genomes and reprogramming the genetic code of living organisms for programmable polymer synthesis and novel biomanufacturing.
Notes
Constructive Bio is a synthetic biology company pioneering approaches for building entirely synthetic genomes and reprogramming the genetic code of living organisms. Their platform enables programmable polymer synthesis and novel biomanufacturing capabilities.
The company was founded based on groundbreaking research from the MRC Laboratory of Molecular Biology (LMB) in Cambridge, including the first complete synthesis of a designer bacterial genome. Their technology opens new possibilities for creating organisms with expanded genetic codes that can produce novel materials and therapeutics.
Team
- Jason Chin, Ph.D. - Co-founder & Scientific Founder
- MRC Laboratory of Molecular Biology
- LinkedIn: linkedin.com/in/jasonchin
Additional Research Findings
- MRC Laboratory of Molecular Biology (LMB) spinout
- Synthetic genome construction
- Genetic code reprogramming
- Programmable polymer synthesis platform
- Novel biomanufacturing applications
- Cambridge, UK headquarters
- Pioneering expanded genetic code technology
- Applications in materials and therapeutics
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| OMX Ventures | San Francisco, California, USA | biotech-focused | seedseries-a | 23 |